Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside.
D000328:Adult; D000368:Aged; D001345:Autoradiography; D001772:Blood Cell Count; D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000494:pharmacology* / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D003864:Depression, Chemical; D004912:Erythrocytes / Q000187:drug effects*; D006801:Humans; D007275:Injections, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D008875:Middle Aged; D008938:Mitosis / Q000187:drug effects*; D013053:Spectrophotometry; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D003561:Cytarabine; D014316:Tritium; D004247:DNA; D013936:Thymidine